Clinical Trial Update: Use Dexmedetomidine To Protect Myocardial Injury Evaluation [Phase 4]

View source ↗

Summary

Clinical trial update indicates a Phase 4 study evaluating dexmedetomidine to protect against myocardial injury in coronary heart disease, currently not yet rec…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Heart Disease
• Myocardial Infarction

Drugs mentioned

• Dexmedetomidine (Dexmedetomidine)

Snippet

Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University | Conditions: Coronary Heart Disease, Myocardial Injury | Phase 4 | Status: NOT_YET_RECRUITING